Skip to main content
Top
Published in: Intensive Care Medicine 5/2004

01-05-2004 | Original

Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults

Authors: Salmaan Kanji, Avinder Singh, Michael Tierney, Hilary Meggison, Lauralyn McIntyre, Paul C. Hebert

Published in: Intensive Care Medicine | Issue 5/2004

Login to get access

Abstract

Objective

Aggressive glycemic control improves mortality and morbidity in critically ill adults, however implementation of such a strategy can be logistically difficult. This study evaluates the efficiency and safety of a nurse-managed insulin protocol in critically ill adults.

Design

Combined retrospective-prospective before-after cohort study.

Setting

Twenty-one bed, medical/surgical ICU in a tertiary care hospital.

Patients

Two cohorts of 50 consecutive ICU patients requiring insulin infusions.

Intervention

Patients in the control cohort received insulin infusions titrated according to target blood glucose ranges and sliding scales at the physician’s discretion. Patients in the interventional cohort received an insulin infusion adjusted using a standardized protocol targeting a blood glucose of 4.5–6.1 mmol/l (81–110 mg/dl).

Measurements and main results

Efficiency was measured by comparing the time to reach, and the time spent within, the target range between cohorts. Safety was assessed by comparing the incidence of severe hypoglycemia, the frequency of rescue dextrose administration and the cumulative time that the infusion was held for hypoglycemia between cohorts. Patients in the interventional cohort reached their target more rapidly (11.3±7.9 vs 16.4±12.6 h; p=0.028) and maintained their blood glucose within the target range longer (11.5±3.7 vs 7.1±5.0 h/day; p<0.001) than controls. The standardized protocol yielded a four-fold reduction in the incidence of severe hypoglycemia (4 vs 16%; p=0.046) and reduced the median frequency of dextrose rescue therapy (0 [0–0.91] vs 0.17 [0–1.2] episodes/patient per day; p=0.01) as compared to controls.

Conclusion

Standardization of intensive insulin therapy improves the efficiency and safety of glycemic control in critically ill adults.
Literature
1.
go back to reference Vincent JL, Abraham E, Annane D, Bernard G, Rivers E, Van den Berghe G (2002) Reducing mortality in sepsis: new directions. Crit Care 6:S1–S18CrossRef Vincent JL, Abraham E, Annane D, Bernard G, Rivers E, Van den Berghe G (2002) Reducing mortality in sepsis: new directions. Crit Care 6:S1–S18CrossRef
2.
go back to reference Montori VM, Bistrian BR, McMahon MM (2002) Hyperglycemia in acutely ill medical patients. JAMA 288:2167–2169CrossRefPubMed Montori VM, Bistrian BR, McMahon MM (2002) Hyperglycemia in acutely ill medical patients. JAMA 288:2167–2169CrossRefPubMed
3.
go back to reference Van den Berghe G (2001) Molecular biology: a timely tool for further unraveling the “diabetes of stress”. Crit Care Med 29:910–911PubMed Van den Berghe G (2001) Molecular biology: a timely tool for further unraveling the “diabetes of stress”. Crit Care Med 29:910–911PubMed
4.
go back to reference Van den Berghe G (2002) Dynamic neuroendocrine responses to critical illness. Front Neuroendocrinol 23:370–391CrossRefPubMed Van den Berghe G (2002) Dynamic neuroendocrine responses to critical illness. Front Neuroendocrinol 23:370–391CrossRefPubMed
5.
go back to reference Mesotten D, Van den Berghe (2003) Clinical potential of insulin therapy in critically ill patients. Drugs 63:625–636 Mesotten D, Van den Berghe (2003) Clinical potential of insulin therapy in critically ill patients. Drugs 63:625–636
6.
go back to reference Mesotten D, Delhanty PJD, Vanderhoydonc F, Hardman KV, Weekers F, Baxter RC, Van den Berghe G (2002) Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. J Clin Endocrinol Metab 87:5516–5523CrossRefPubMed Mesotten D, Delhanty PJD, Vanderhoydonc F, Hardman KV, Weekers F, Baxter RC, Van den Berghe G (2002) Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. J Clin Endocrinol Metab 87:5516–5523CrossRefPubMed
7.
go back to reference McCowen KC, Ling PR, Ciccarone A, Mao Y, Chow JC, Bistrian BR, Smith RJ (2001) Sustained endotoxemia leads to marked down-regulation of early steps in the insulin-signaling cascade. Crit Care Med 29:839–846 McCowen KC, Ling PR, Ciccarone A, Mao Y, Chow JC, Bistrian BR, Smith RJ (2001) Sustained endotoxemia leads to marked down-regulation of early steps in the insulin-signaling cascade. Crit Care Med 29:839–846
8.
go back to reference Finney SJ, Zekveld C, Elia A, Evans TW (2003) Glucose control and mortality in critically ill patients. JAMA 290:2041–2047CrossRefPubMed Finney SJ, Zekveld C, Elia A, Evans TW (2003) Glucose control and mortality in critically ill patients. JAMA 290:2041–2047CrossRefPubMed
9.
go back to reference Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367PubMed Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367PubMed
10.
go back to reference Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P (2003) Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31:359–366PubMed Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P (2003) Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31:359–366PubMed
11.
go back to reference Meade MO, Ely EW (2002) Protocols to improve the care of critically ill pediatric and adult patients. JAMA 288:2601–2603PubMed Meade MO, Ely EW (2002) Protocols to improve the care of critically ill pediatric and adult patients. JAMA 288:2601–2603PubMed
12.
go back to reference Ober KP (1997) Alterations in fuel metabolism in critical illness: hypoglycemia. In: Ober KP (ed) Endocrinology of critical disease. Humana Press, Totowa, NJ, pp 211–231 Ober KP (1997) Alterations in fuel metabolism in critical illness: hypoglycemia. In: Ober KP (ed) Endocrinology of critical disease. Humana Press, Totowa, NJ, pp 211–231
Metadata
Title
Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults
Authors
Salmaan Kanji
Avinder Singh
Michael Tierney
Hilary Meggison
Lauralyn McIntyre
Paul C. Hebert
Publication date
01-05-2004
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 5/2004
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-004-2252-2

Other articles of this Issue 5/2004

Intensive Care Medicine 5/2004 Go to the issue